analgesic therapy and a problem of comorbidity
Clicks: 336
ID: 137204
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
336 views
42 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #1 of 8 articles by views in philosophy and culture
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Analgesic therapy is an essential element of combination treatment in patients with rheumatic diseases (RDs). However, pain killers can cause serious complications. This risk is especially great in patients with comorbidities. Therefore, the individual choice of pharmacological agents for controlling acute and chronic pain in a particular patient largely depends on the presence of comorbidity. This review discusses the incidence of comorbidities in different RDs, the characteristics of adverse reactions from the intake of main analgesics, such as paracetamol, opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), as well as the rational choice of a NSAID in real clinical practice.
| Reference Key |
karateev2019sovremennaanalgesic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;A. E. Karateev |
| Journal | philosophy and culture |
| Year | 2019 |
| DOI |
10.14412/1996-7012-2019-3-116-125
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.